FTD与ALS遗传突变患病率的性别差异:一项Meta分析
该Meta分析纳入32篇ALS研究(12,784例)、23篇FTD研究(5,320例)及36篇GRN相关FTD研究(3,857例)等,评估C9orf72、GRN、MAPT突变患病率的性别差异。结果显示ALS中C9orf72突变女性患病率较高(RR 1.16,95%CI 1.04-1.29),FTD中GRN突变女性患病率较高(RR 1.33,95%CI 1.09-1.62),而C9orf72相关FTD和MAPT相关FTD无性别差异。提示性别相关风险因素可能调节C9orf72和GRN介导的表型表达。
要点
- ALS患者中C9orf72突变女性患病率显著高于男性(RR 1.16)。
- FTD患者中GRN突变女性患病率显著高于男性(RR 1.33)。
- C9orf72相关FTD和MAPT相关FTD未发现性别差异。
核心结论
- ALS中C9orf72突变和FTD中GRN突变的女性患病率较高,提示性别相关风险因素可能调节C9orf72和GRN介导的表型表达。
研究设计与样本
- 系统检索MEDLINE、EMBASE和PsycINFO数据库(建库至2016年6月30日),纳入报告FTD或ALS患者男女突变携带者数量的研究,采用随机效应模型计算女性与男性汇总风险比(RR)及95%置信区间(CI)。
- 纳入32篇ALS文章共12,784例患者(含1,244例C9orf72突变携带者)。
- 纳入23篇FTD文章共5,320例患者(含488例C9orf72突变携带者)。
- 纳入36篇FTD文章共3,857例患者(含369例GRN突变携带者)。
- 纳入21篇FTD文章共2,377例患者(含215例MAPT突变携带者)。
主要发现
- ALS患者中C9orf72突变女性患病率高于男性(RR 1.16,95%CI 1.04-1.29)。
- FTD患者中C9orf72突变无性别差异(RR 0.95,95%CI 0.81-1.12)。
- FTD患者中GRN突变女性患病率高于男性(RR 1.33,95%CI 1.09-1.62)。
- FTD患者中MAPT突变无性别差异(RR 1.21,95%CI 0.95-1.55)。
临床怎么用
- 在ALS和FTD的遗传咨询与基因检测中,应关注C9orf72和GRN突变的性别差异,女性携带者可能具有更高的外显风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To conduct a meta-analysis that investigates sex differences in the prevalence of mutations in the 3 most common genes that cause amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)-chromosome 9 open reading frame 72 (C9orf72), progranulin (GRN), or microtubule-associated protein tau (MAPT)-in patients clinically diagnosed with these conditions. METHODS: MEDLINE, EMBASE, and PsycINFO databases were searched (inception to June 30, 2016). Studies of patients with FTD or ALS that reported the number of men and women with and without mutations of interest were selected. Female to male pooled risk ratios (RR) and 95% confidence intervals (CI) for each mutation were calculated using random-effects models. RESULTS: Thirty-two articles reporting 12,784 patients with ALS (including 1,244 C9orf72 mutation carriers) revealed a higher prevalence of female patients with C9orf72-related ALS (RR 1.16, 95% CI 1.04-1.29). Twenty-three articles reporting 5,320 patients with FTD (including 488 C9orf72 mutation carriers) revealed no sex differences in C9orf72-related FTD (RR 0.95, 95% CI 0.81-1.12). Thirty-six articles reporting 3,857 patients with FTD (including 369 GRN mutation carriers) revealed a higher prevalence of female patients with GRN-related FTD (RR 1.33, 95% CI 1.09-1.62). Finally, 21 articles reporting 2,377 patients with FTD (including 215 MAPT mutation carriers) revealed no sex difference in MAPT-related FTD (RR 1.21, 95% CI 0.95-1.55). CONCLUSIONS: Higher female prevalence of C9orf72 hexanucleotide repeat expansions in ALS and GRN mutations in FTD suggest that sex-related risk factors might moderate C9orf72 and GRN-mediated phenotypic expression.
引用
- Curtis AF, Masellis M, Hsiung GR, et al. Sex differences in the prevalence of genetic mutations in FTD and ALS: A meta-analysis. Neurology. 2017. PMID: 28916533. doi:10.1212/WNL.0000000000004494
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。